The critical pathophysiological scenarios of severe morbid COVID-19 manifestations (reviewed in [19]), particularly venous microthrombosis, did not occur under severe inflammatory conditions mediated by other viruses [20] and reaches beyond inhibition of the catalytic function of ACE2. This evidence concerns the gene ACE2 and COVID-19.